Inhibition of activin a ameliorates skeletal muscle injury and rescues contractile properties by inducing efficient remodeling in female mice

American Journal of Pathology

Volumn 184, Issue 4, 2014, Pages 1152-1166

  Yaden, Benjamin C ^a,b   Wang, Yan X ^b   Wilson, Jonathan M ^a,b   Culver, Alexander E ^b   Milner, Andrea ^b   Datta Mannan, Amita ^b   Shetler, Pamela ^b   Croy, Johnny E ^b   Dai, Guoli ^a   Krishnan, Venkatesh ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN A; ATROGIN 1; CARDIOTOXIN; GROWTH DIFFERENTIATION FACTOR 15; IMMUNOGLOBULIN G1; INHIBIN A; INTERLEUKIN 17; INTERLEUKIN 6; LYMPHOTOXIN; MESSENGER RNA; TUMOR NECROSIS FACTOR; ACTIVIN; TRANSCRIPTOME;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL DISEASE; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; MOUSE; MUSCLE ATROPHY; MUSCLE CONTRACTILITY; MUSCLE FUNCTION; MUSCLE INJURY; MUSCLE LENGTH; MUSCLE MASS; MUSCLE REGENERATION; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; MUSCLE CONTRACTION; PHYSIOLOGY; REGENERATION; SKELETAL MUSCLE;

ACTIVINS; ANIMALS; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; MICE, INBRED C57BL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; REGENERATION; TRANSCRIPTOME;

EID: 84897903860     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.12.029     Document Type: Article

References (67)

1. J. Massague TGFbeta signalling in context Nat Rev Mol Cell Biol 13 2012 616 630
2. M. Bartoli, J. Poupiot, A. Vulin, F. Fougerousse, L. Arandel, N. Daniele, C. Roudaut, F. Noulet, L. Garcia, O. Danos, and I. Richard AAV-mediated delivery of a mutated myostatin propeptide ameliorates calpain 3 but not alpha-sarcoglycan deficiency Gene Ther 14 2007 733 740
3. S. Bogdanovich, T.O. Krag, E.R. Barton, L.D. Morris, L.A. Whittemore, R.S. Ahima, and T.S. Khurana Functional improvement of dystrophic muscle by myostatin blockade Nature 420 2002 418 421
4. Y. Ohsawa, H. Hagiwara, M. Nakatani, A. Yasue, K. Moriyama, T. Murakami, K. Tsuchida, S. Noji, and Y. Sunada Muscular atrophy of caveolin-3-deficient mice is rescued by myostatin inhibition J Clin Invest 116 2006 2924 2934
5. S.A. Parsons, D.P. Millay, M.A. Sargent, E.M. McNally, and J.D. Molkentin Age-dependent effect of myostatin blockade on disease severity in a murine model of limb-girdle muscular dystrophy Am J Pathol 168 2006 1975 1985
6. C. Qiao, J. Li, J. Jiang, X. Zhu, B. Wang, and X. Xiao Myostatin propeptide gene delivery by adeno-associated virus serotype 8 vectors enhances muscle growth and ameliorates dystrophic phenotypes in mdx mice Hum Gene Ther 19 2008 241 254
7. K.R. Wagner, X. Liu, X. Chang, and R.E. Allen Muscle regeneration in the prolonged absence of myostatin Proc Natl Acad Sci U S A 102 2005 2519 2524
8. C. McFarlane, A. Hennebry, M. Thomas, E. Plummer, N. Ling, M. Sharma, and R. Kambadur Myostatin signals through Pax7 to regulate satellite cell self-renewal Exp Cell Res 314 2008 317 329
9. S. McCroskery, M. Thomas, L. Maxwell, M. Sharma, and R. Kambadur Myostatin negatively regulates satellite cell activation and self-renewal J Cell Biol 162 2003 1135 1147
10. A.C. McPherron, A.M. Lawler, and S.J. Lee Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member Nature 387 1997 83 90
11. S.L. Mellor, M. Cranfield, R. Ries, J. Pedersen, B. Cancilla, D. de Kretser, N.P. Groome, A.J. Mason, and G.P. Risbridger Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in human prostate and evidence for formation of new activin heterodimers of beta(C)-subunit J Clin Endocrinol Metab 85 2000 4851 4858
12. S.L. Mellor, E.M. Ball, A.E. O'Connor, J.F. Ethier, M. Cranfield, J.F. Schmitt, D.J. Phillips, N.P. Groome, and G.P. Risbridger Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate Endocrinology 144 2003 4410 4419
13. H.G. Burger, R.I. McLachlan, M. Bangah, H. Quigg, J.K. Findlay, D.M. Robertson, D.M. de Kretser, G.L. Warne, G.A. Werther, I.L. Hudson, J.J. Cook, R. Fiedler, S. Greco, A.B.W. Yong, and P. Smith Serum inhibin concentrations rise throughout normal male and female puberty J Clin Endocrinol Metab 67 1988 689 694
14. D. Huylebroeck, K. Van Nimmen, A. Waheed, K. von Figura, A. Marmenout, L. Fransen, P. De Waele, J.M. Jaspar, P. Franchimont, H. Stunnenberg, and H. Van Heuverswijn Expression and processing of the activin-A/erythroid differentiation factor precursor: a member of the transforming growth factor-beta superfamily Mol Endocrinol 4 1990 1153 1165
15. A.M. Gray, and A.J. Mason Requirement for activin A and transforming growth factor-beta 1 pro-regions in homodimer assembly Science 247 1990 1328 1330
16. L. Attisano, J.L. Wrana, S. Cheifetz, and J. Massague Novel activin receptors: distinct genes and alternative mRNA splicing generate a repertoire of serine/threonine kinase receptors Cell 68 1992 97 108
17. G. Leto Activin A and bone metastasis J Cell Physiol 225 2010 302 309
18. G. Leto, L. Incorvaia, G. Badalamenti, F.M. Tumminello, N. Gebbia, C. Flandina, M. Crescimanno, and G. Rini Activin A circulating levels in patients with bone metastasis from breast or prostate cancer Clin Exp Metastasis 23 2006 117 122
19. S. Lotinun, R.S. Pearsall, M.V. Davies, T.H. Marvell, T.E. Monnell, J. Ucran, R.J. Fajardo, R. Kumar, K.W. Underwood, J. Seehra, M.L. Bouxsein, and R. Baron A soluble activin receptor Type IIA fusion protein (ACE-011) increases bone mass via a dual anabolic-antiresorptive effect in Cynomolgus monkeys Bone 46 2010 1082 1088
20. E. Terpos, E. Kastritis, D. Christoulas, M. Gkotzamanidou, E. Eleutherakis-Papaiakovou, N. Kanellias, A. Papatheodorou, and M.A. Dimopoulos Circulating activin-A is elevated in patients with advanced multiple myeloma and correlates with extensive bone involvement and inferior survival: no alterations post-lenalidomide and dexamethasone therapy Ann Oncol 23 2012 2681 2686
21. R.J. Fajardo, R.K. Manoharan, R.S. Pearsall, M.V. Davies, T. Marvell, T.E. Monnell, J.A. Ucran, A.E. Pearsall, D. Khanzode, R. Kumar, K.W. Underwood, B. Roberts, J. Seehra, and M.L. Bouxsein Treatment with a soluble receptor for activin improves bone mass and structure in the axial and appendicular skeleton of female cynomolgus macaques (Macaca fascicularis) Bone 46 2010 64 71
22. S.J. Lee Quadrupling muscle mass in mice by targeting TGF-beta signaling pathways PLoS One 2 2007 e789
23. X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, D.L. Lacey, A.L. Goldberg, and H.Q. Han Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival Cell 142 2010 531 543
24. H. Gilson, O. Schakman, S. Kalista, P. Lause, K. Tsuchida, and J.P. Thissen Follistatin induces muscle hypertrophy through satellite cell proliferation and inhibition of both myostatin and activin Am J Physiol Endocrinol Metab 297 2009 E157 E164
25. S.J. Lee, and A.C. McPherron Regulation of myostatin activity and muscle growth Proc Natl Acad Sci U S A 98 2001 9306 9311
26. K.L. Jones, A. Mansell, S. Patella, B.J. Scott, M.P. Hedger, D.M. de Kretser, and D.J. Phillips Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemia Proc Natl Acad Sci U S A 104 2007 16239 16244
27. D.J. Phillips, D.M. de Kretser, and M.P. Hedger Activin and related proteins in inflammation: not just interested bystanders Cytokine Growth Factor Rev 20 2009 153 164
28. M. Fumagalli, T. Musso, W. Vermi, S. Scutera, R. Daniele, D. Alotto, I. Cambieri, A. Ostorero, F. Gentili, P. Caposio, M. Zucca, S. Sozzani, M. Stella, and C. Castagnoli Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin Exp Dermatol 16 2007 600 610
29. D.J. Garry, A. Meeson, J. Elterman, Y. Zhao, P. Yang, R. Bassel-Duby, and R.S. Williams Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF Proc Natl Acad Sci U S A 97 2000 5416 5421
30. T.J. Burkholder, B. Fingado, S. Baron, and R.L. Lieber Relationship between muscle fiber types and sizes and muscle architectural properties in the mouse hindlimb J Morphol 221 1994 177 190
31. S.B. Charge, and M.A. Rudnicki Cellular and molecular regulation of muscle regeneration Physiol Rev 84 2004 209 238
32. D.J. Garry, Q. Yang, R. Bassel-Duby, and R.S. Williams Persistent expression of MNF identifies myogenic stem cells in postnatal muscles Dev Biol 188 1997 280 294
33. V. Prisk, and J. Huard Muscle injuries and repair: the role of prostaglandins and inflammation Histol Histopathol 18 2003 1243 1256
34. J. Huard, Y. Li, and F.H. Fu Muscle injuries and repair: current trends in research J Bone Joint Surg Am 84-A 2002 822 832
35. D. Yin, and J.G. Tang Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo FEBS Lett 495 2001 16 20
36. M. Kawai, K. Bessho, H. Maruyama, J. Miyazaki, and T. Yamamoto Simultaneous gene transfer of bone morphogenetic protein (BMP)-2 and BMP-7 by in vivo electroporation induces rapid bone formation and BMP-4 expression BMC Musculoskelet Disord 7 2006 62
37. A.C. Durieux, A. Amirouche, S. Banzet, N. Koulmann, R. Bonnefoy, M. Pasdeloup, C. Mouret, X. Bigard, A. Peinnequin, and D. Freyssenet Ectopic expression of myostatin induces atrophy of adult skeletal muscle by decreasing muscle gene expression Endocrinology 148 2007 3140 3147
38. I.D. Haidl, and W.A. Jefferies The macrophage cell surface glycoprotein F4/80 is a highly glycosylated proteoglycan Eur J Immunol 26 1996 1139 1146
39. S. Bhatnagar, and A. Kumar The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting Curr Mol Med 12 2012 3 13
40. S.N. Breit, H. Johnen, A.D. Cook, V.W. Tsai, M.G. Mohammad, T. Kuffner, H.P. Zhang, C.P. Marquis, L. Jiang, G. Lockwood, M. Lee-Ng, Y. Husaini, L. Wu, J.A. Hamilton, and D.A. Brown The TGF-beta superfamily cytokine, MIC-1/GDF15: a pleotrophic cytokine with roles in inflammation, cancer and metabolism Growth Factors 29 2011 187 195
41. J.J. Hulmi, B.M. Oliveira, M. Silvennoinen, W.M. Hoogaars, H. Ma, P. Pierre, A. Pasternack, H. Kainulainen, and O. Ritvos Muscle protein synthesis, mTORC1/MAPK/Hippo signaling, and capillary density are altered by blocking of myostatin and activins Am J Physiol Endocrinol Metab 304 2013 E41 E50
42. Q. Wang, and A.C. McPherron Myostatin inhibition induces muscle fibre hypertrophy prior to satellite cell activation J Physiol 590 2012 2151 2165
43. L. He, K. Vichev, R. Macharia, R. Huang, B. Christ, K. Patel, and H. Amthor Activin A inhibits formation of skeletal muscle during chick development Anat Embryol 209 2005 401 407
44. Wagner KR: Myostatin-Related Muscle Hypertrophy. Edited by RA Pagon, TD Bird, CR Dolan, K Stephens, MP Adam. In GeneReviews [Internet]. Copyright University of Washington, Seattle. 1993. Available at http://www.ncbi.nlm.nih. gov/books/NBK1499, last revised July 3, 2013
45. A. Kumar, S. Bhatnagar, and P.K. Paul TWEAK and TRAF6 regulate skeletal muscle atrophy Curr Opin Clin Nutr Metab Care 15 2012 233 239
46. R.A. Collins, and M.D. Grounds The role of tumor necrosis factor-alpha (TNF-alpha) in skeletal muscle regeneration: studies in TNF-alpha(-/-) and TNF-alpha(-/-)/LT-alpha(-/-) mice J Histochem Cytochem 49 2001 989 1001
47. M. Saclier, S. Cuvellier, M. Magnan, R. Mounier, and B. Chazaud Monocyte/macrophage interactions with myogenic precursor cells during skeletal muscle regeneration FEBS J 280 2013 4118 4130
48. T. Kempf, A. Zarbock, C. Widera, S. Butz, A. Stadtmann, J. Rossaint, M. Bolomini-Vittori, M. Korf-Klingebiel, L.C. Napp, B. Hansen, A. Kanwischer, U. Bavendiek, G. Beutel, M. Hapke, M.G. Sauer, C. Laudanna, N. Hogg, D. Vestweber, and K.C. Wollert GDF-15 is an inhibitor of leukocyte integrin activation required for survival after myocardial infarction in mice Nat Med 17 2011 581 588
49. L. Arnold, A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R.K. Gherardi, and B. Chazaud Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis J Exp Med 204 2007 1057 1069
50. E. Sierra-Filardi, A. Puig-Kroger, F.J. Blanco, C. Nieto, R. Bragado, M.I. Palomero, C. Bernabeu, M.A. Vega, and A.L. Corbi Activin A skews macrophage polarization by promoting a proinflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers Blood 117 2011 5092 5101
51. V. Siriett, M.S. Salerno, C. Berry, G. Nicholas, R. Bower, R. Kambadur, and M. Sharma Antagonism of myostatin enhances muscle regeneration during sarcopenia Mol Ther 15 2007 1463 1470
52. C.J. Mann, E. Perdiguero, Y. Kharraz, S. Aguilar, P. Pessina, A.L. Serrano, and P. Munoz-Canoves Aberrant repair and fibrosis development in skeletal muscle Skelet Muscle 1 2011 21
53. M. Girgenrath, S. Weng, C.A. Kostek, B. Browning, M. Wang, S.A. Brown, J.A. Winkles, J.S. Michaelson, N. Allaire, P. Schneider, M.L. Scott, Y.M. Hsu, H. Yagita, R.A. Flavell, J.B. Miller, L.C. Burkly, and T.S. Zheng TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration EMBO J 25 2006 5826 5839
54. J.A. Winkles The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Nat Rev Drug Discov 7 2008 411 425
55. M.B. Torchinsky, and J.M. Blander T helper 17 cells: discovery, function, and physiological trigger Cell Mol Life Sci 67 2010 1407 1421
56. L. De Pasquale, A. D'Amico, M. Verardo, S. Petrini, E. Bertini, and F. De Benedetti Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy Neurology 78 2012 1309 1314
57. J. Kocic, J.F. Santibanez, A. Krstic, S. Mojsilovic, V. Ilic, and D. Bugarski Interleukin-17 modulates myoblast cell migration by inhibiting urokinase type plasminogen activator expression through p38 mitogen-activated protein kinase Int J Biochem Cell Biol 45 2013 464 475
58. K. Sugama, K. Suzuki, K. Yoshitani, K. Shiraishi, and T. Kometani IL-17, neutrophil activation and muscle damage following endurance exercise Exerc Immunol Rev 18 2012 116 127
59. Y. Liang, A. Inukai, S. Kuru, T. Kato, M. Doyu, and G. Sobue The role of lymphotoxin in pathogenesis of polymyositis Acta Neuropathol 100 2000 521 527
60. E.Y. Chiang, G.A. Kolumam, X. Yu, M. Francesco, S. Ivelja, I. Peng, P. Gribling, J. Shu, W.P. Lee, C.J. Refino, M. Balazs, A. Paler-Martinez, A. Nguyen, J. Young, K.H. Barck, R.A. Carano, R. Ferrando, L. Diehl, D. Chatterjea, and J.L. Grogan Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease Nat Med 15 2009 766 773
61. J. Alter, D. Rozentzweig, and E. Bengal Inhibition of myoblast differentiation by tumor necrosis factor alpha is mediated by c-Jun N-terminal kinase 1 and leukemia inhibitory factor J Biol Chem 283 2008 23224 23234
62. D.R. Marsh, J.A. Carson, L.N. Stewart, and F.W. Booth Activation of the skeletal alpha-actin promoter during muscle regeneration J Muscle Res Cell Motil 19 1998 897 907
63. J.L. Shadrach, and A.J. Wagers Stem cells for skeletal muscle repair Philos Trans R Soc Lond B Biol Sci 366 2011 2297 2306
64. S.J. Lee, and A.C. McPherron Myostatin and the control of skeletal muscle mass Curr Opin Genet Dev 9 1999 604 607
65. M. Sharma, B. Langley, J. Bass, and R. Kambadur Myostatin in muscle growth and repair Exerc Sport Sci Rev 29 2001 155 158
66. Z. Yablonka-Reuveni Myostatin blockade: a new way to enhance skeletal muscle repair in old age? Mol Ther 15 2007 1407 1409
67. S.L. Welle Myostatin and muscle fiber size: focus on "Smad2 and 3 transcription factors control muscle mass in adulthood" and "Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size." Am J Physiol Cell Physiol 296 2009 C1245 C1247